Glossary
S
Continuity of care provided when transitioning from one health care setting to another, allowing pharmacy care to be carried out without any…
Self-medication is the treatment of common health problems with medicines especially designed and labelled for use without medical supervision and…
Wholesale distribution offering a limited range of medicines available in a defined market.
Synonym: Short-Line wholesaling, Short-liner
In German…
A single social health insurance institution. In some countries there are several sickness funds operating (Austria) or even competing each other (…
Wholesale distribution scheme in which a wholesaler has the exclusive right to distribute medicines – usually all products – of one manufacturer.
In…
A medicine that can be purchased from one manufacturer since it is patent-protected (on-patent medicine).
Synonym: generic
Last update: 30 June 2023…
A system of financing health care funded through insurance contributions by employers and employees as well as state subsidies.
In German: Soziale…
A person or organisation with a legitimate interest in a topic related to health care. Stakeholders may be:
- pharmaceutical manufacturers
-…
Pricing procedure, where medicine prices are set on a regulatory basis (e.g. law, enactment, decree).
Last update: 30 June 2023
Source: PPRI
Management of medicine stocks in a hospital or any other step of a delivery chain.
Good distribution practices suggest the following principles for…
The storing of pharmaceutical products up to the point of use.
Last update: 30 June 2023
Source: WHO, updated by PPRI
SPC gives original products a complementary period of market exclusivity beyond patent expiry to compensate for delays of marketing in the…
Persons or company providing medicines on request. Suppliers include manufacturers, distribution actors and (parallel) traders.
Last update: 30 June…
Schedule of quantities of a product (good/service) that potential sellers are willing and able to sell at a given price during a certain period and…
Policies that are applied by governments (e.g. public authorities and public payers in the healthcare system) to control prices and/or profit, manage…
A biomarker that is intended to substitute for a clinical endpoint. A surrogate endpoint is expected to predict clinical benefit (or harm or lack of…
The capacity to meet the needs of the present without compromising the ability to meet future needs.
Last update: 30 June 2023
Source: WHO, updated…
Reclassification of a prescription-only medicine (POM) to an non-prescription medicine (NPM).
Action by a prescriber to change medication (e.g. from…